These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2093110)

  • 1. Failure of ciprofloxacin to eradicate brucellosis in experimental animals.
    al-Orainey IO; Bashandi AM; Saeed EN
    J Chemother; 1990 Dec; 2(6):380-3. PubMed ID: 2093110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of experimental murine brucellosis with streptomycin alone and in combination with ciprofloxacin, doxycycline, and rifampin.
    Lang R; Shasha B; Rubinstein E
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2333-6. PubMed ID: 8285615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampin in the treatment of experimental brucellosis in mice and guinea pigs.
    Philippon AM; Plommet MG; Kazmierczak A; Marly JL; Nevot PA
    J Infect Dis; 1977 Oct; 136(4):481-8. PubMed ID: 409786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of experimental brucellosis of mice and guinea pigs by rifampicin].
    Philippon A; Kazmierczak A; Plommet M; Marly J; Nevot P
    Dev Biol Stand; 1976; 31():279-86. PubMed ID: 816684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of ciprofloxacin versus doxycycline as prophylaxis against experimental murine Brucella melitensis infection.
    Atkins HS; Spencer S; Brew SD; Jenner DC; Russell P; MacMillan AP; Eley SM; Simpson AJ
    Int J Antimicrob Agents; 2009 Nov; 34(5):474-6. PubMed ID: 19500948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of prolonged treatment with ciprofloxacin in acute infections due to Brucella melitensis.
    Lang R; Raz R; Sacks T; Shapiro M
    J Antimicrob Chemother; 1990 Dec; 26(6):841-6. PubMed ID: 2081722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ciprofloxacin in the treatment of patients with brucellosis].
    Duĭsenova AK; Kurmanova KB; Kurmanova GM
    Antibiot Khimioter; 2002; 47(10):3-7. PubMed ID: 12674788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of ciprofloxacin for treatment of Brucella melitensis infections.
    al-Sibai MB; Halim MA; el-Shaker MM; Khan BA; Qadri SM
    Antimicrob Agents Chemother; 1992 Jan; 36(1):150-2. PubMed ID: 1590681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant prevention concentrations of tetracycline, rifampicin and ciprofloxacin for Brucellae melitensis.
    Coban AY; Tanyel E; Tasdelen Fisgin N; Darka O; Tulek N; Durupinar B
    J Chemother; 2007 Oct; 19(5):596-8. PubMed ID: 18073161
    [No Abstract]   [Full Text] [Related]  

  • 10. [A rare agent of pneumonia: Brucella melitensis].
    Oztürk O; Akçam Z; Sahin U; Bircan A; Akkaya A; Yayli G
    Tuberk Toraks; 2008; 56(4):443-7. PubMed ID: 19123082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of Brucella melitensis end-carditis.
    Pratt DS; Tenney JH; Bjork CM; Reller LB
    Am J Med; 1978 May; 64(5):897-900. PubMed ID: 645754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of 106 cases of human brucellosis.
    Shehabi A; Shakir K; el-Khateeb M; Qubain H; Fararjeh N; Shamat AR
    J Infect; 1990 Jan; 20(1):5-10. PubMed ID: 2299182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter-defibrillator infection due to Brucella melitensis: case report and review of brucellosis of cardiac devices.
    Dhand A; Ross JJ
    Clin Infect Dis; 2007 Feb; 44(4):e37-9. PubMed ID: 17243046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of a short-term antibiotic therapy for human brucellosis using ciprofloxacin. A study on in vitro susceptibility of Brucella strains.
    Al Dahouk S; Hagen RM; Nockler K; Tomaso H; Wittig M; Scholz HC; Vergnaud G; Neubauer H
    Chemotherapy; 2005 Oct; 51(6):352-6. PubMed ID: 16227689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of long-term ethanol feeding on Brucella melitensis infection of rats.
    Yumuk Z; Ozdemirci S; Erden BF; Dundar V
    Alcohol Alcohol; 2001; 36(4):314-7. PubMed ID: 11468131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute pancreatitis associated with brucellosis.
    al-Awadhi NZ; Ashkenani F; Khalaf ES
    Am J Gastroenterol; 1989 Dec; 84(12):1570-4. PubMed ID: 2688402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative activity of azithromycin and doxycycline against Brucella spp. infection in mice.
    Domingo S; Gastearena I; Vitas AI; López-Goñi I; Dios-Viéitez C; Díaz R; Gamazo C
    J Antimicrob Chemother; 1995 Oct; 36(4):647-56. PubMed ID: 8591939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis.
    López-Merino A; Contreras-Rodríguez A; Migranas-Ortiz R; Orrantia-Gradín R; Hernández-Oliva GM; Gutiérrez-Rubio AT; Cardeñosa O
    Scand J Infect Dis; 2004; 36(9):636-8. PubMed ID: 15370648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis.
    Bosch J; Liñares J; López de Goicoechea MJ; Ariza J; Cisnal MC; Martin R
    J Antimicrob Chemother; 1986 Apr; 17(4):459-61. PubMed ID: 2940209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of combinations of doxycycline and rifampicin in the therapy of experimental mouse brucellosis.
    Shasha B; Lang R; Rubinstein E
    J Antimicrob Chemother; 1994 Mar; 33(3):545-51. PubMed ID: 8040118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.